These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7050977)

  • 1. Comparison of alternate day steroids and daily steroids in renal transplant recipients.
    Davisson NA; Westervelt FB; Bolton WK
    Proc Clin Dial Transplant Forum; 1980; 10():150-4. PubMed ID: 7050977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful immunosuppression of renal allograft recipients with alternate day steroid therapy.
    Burleson RL; Scruggs BF; Brennan A
    Clin Nephrol; 1978 Sep; 10(3):87-9. PubMed ID: 359210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy.
    Curtis JJ; Galla JH; Kotchen TA; Lucas B; McRoberts JW; Luke RG
    Clin Nephrol; 1976 Mar; 5(3):123-7. PubMed ID: 770034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternate day steroids in renal transplant patients.
    Gelman ML; Delmonico FL; Fulton B; Re R; Cosimi AB
    Proc Clin Dial Transplant Forum; 1977; 7():126-33. PubMed ID: 356033
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternate day prednisone treatment may increase kidney transplant rejection.
    Leb DE
    Proc Clin Dial Transplant Forum; 1979; 9():136-9. PubMed ID: 399501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternate day steroids and blood pressure control after renal transplantation.
    McHugh MI; Tanboga H; Wilkinson R
    Proc Eur Dial Transplant Assoc; 1980; 17():496-501. PubMed ID: 7017696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
    Roberti I; Reisman L; Lieberman KV; Burrows L
    Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension in a pediatric and adolescent population following kidney transplantation.
    Fennell RS; Zalenski R; Geary DF; Iravani A; Garin EH; Pfaff WW; Howard RJ; Brient BW; Walker D; Richard GA
    Int J Pediatr Nephrol; 1981 Jun; 2(2):89-95. PubMed ID: 7042620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prednisone dose spacing on plasma lipids.
    Galla JH; Curtis JJ; Woodford SY; Rees ED; Somes GW; Luke RG
    J Lab Clin Med; 1980 Jun; 95(6):801-7. PubMed ID: 6991620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranous nephropathy with chronic renal failure. Partial native renal function recovery after unsuccessful renal transplant.
    Chopra S; Kaufman JS; Hamburger RJ; Flamenbaum W
    Arch Intern Med; 1980 Mar; 140(3):437-8. PubMed ID: 6987969
    [No Abstract]   [Full Text] [Related]  

  • 11. Steroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: adrenal response and clinical implications.
    Miozzari M; Ambühl PM
    Nephrol Dial Transplant; 2004 Oct; 19(10):2615-21. PubMed ID: 15280521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of alternate-day steroids on renal transplant function. A controlled study.
    McDonald FD; Horensten ML; Mayor GB; Turcotte JG; Selezinka W; Schork MA
    Nephron; 1976; 17(6):415-29. PubMed ID: 796739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednisone withdrawal in pediatric kidney transplant recipients on tacrolimus-based immunosuppression: four-year data.
    Hamiwka LA; Burns A; Bell L
    Pediatr Transplant; 2006 May; 10(3):337-44. PubMed ID: 16677358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
    Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC; Rohrer RM; Kaplan MM
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid-related complications in the cyclosporine era.
    Fryer JP; Granger DK; Leventhal JR; Gillingham K; Najarian JS; Matas AJ
    Clin Transplant; 1994 Jun; 8(3 Pt 1):224-9. PubMed ID: 8061360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
    Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH
    Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of prednisone after oral administration in children with renal grafts. Changes induced by phenobarbital and renal insufficiency].
    Perignon F; Pecquinot MA; Ged C; Antignac C; Guest G; Tete MJ; Broyer M; Lenoir G
    Arch Fr Pediatr; 1985; 42 Suppl 1():639-44. PubMed ID: 3909980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantage of long-term alternate day steroid therapy in renal transplantation: a controlled study.
    Dumler F; Levin NW; Szego G; Vulpetti AT; Preuss LE
    Proc Clin Dial Transplant Forum; 1980; 10():215-9. PubMed ID: 6810344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.